Cardiometabolic

Home / Cardiometabolic

AB Pharma’s Cardiometabolic portfolio offers a comprehensive range of innovative and high-quality medicines designed to support cardiovascular and metabolic health. Each product is developed with precision to ensure efficacy, safety, and patient-centered care, addressing a wide spectrum of cardiometabolic conditions.

Key Products Include:

1. Advant® (Candesartan cilexetil)

Effective management of hypertension and heart-related conditions.

2. Advantec® (Candesartan cilexetil + Hydrochlorothiazide)

Combination therapy for enhanced blood pressure control.

3. Apixaget® (Apixaban)

Advanced anticoagulant therapy for preventing stroke and systemic embolism.

4. Basagine® / Basagine® Pen (Insulin Glargine rDNA)

Long-acting insulin formulations for optimal diabetes management.

5. Co-Tasmi® (Telmisartan + Hydrochlorothiazide)

Targeted combination therapy for blood pressure regulation.

6. Cova® / Cova®-H (Valsartan ± Hydrochlorothiazide)

Effective angiotensin receptor blocker therapy, alone or in combination for better hypertension control.

7. Covam® / Covam®Plus (Amlodipine + Valsartan ± Hydrochlorothiazide)

Multi-action therapies for improved cardiovascular outcomes and patient compliance.

Our cardiometabolic medicines are backed by rigorous research, advanced formulation technology, and a patient-first approach, ensuring that individuals receive therapies that improve cardiovascular health, manage blood pressure, and optimize metabolic function.

AB Pharma continues to lead in delivering trusted, innovative solutions that empower patients and healthcare professionals to achieve better cardiometabolic outcomes.

Critical Situation?

Immediate medical support whenever you need it.

Phone

Email

Location